Axial spondyloarthritis (axSpA) is a type of inflammatory arthritis that affects the spinal joints and the joints that connect the bottom of the spine to the hip bones (the sacroiliac joints). Experts ...

Spondyloarthritis is a group of inflammatory joint diseases that affect the spine and, in some cases, the peripheral joints of the arms and legs. Some forms of spondyloarthritis may also involve the ...

Atul A. Deodhar, MD: Axial spondyloarthritis is an umbrella term that includes nonradiographic axial spondyloarthritis and ankylosing spondylitis. There is a lot of confusion about this term. In ...

Please provide your email address to receive an email when new articles are posted on . ORLANDO, Fla. — Understanding the nuances of spondyloarthropathy diagnostic criteria can help prevent ...

Atul A. Deodhar, MD: Like everything in medicine, the diagnosis of axial spondyloarthritis is based on pattern recognition. If a patient comes in with back pain, the first thing you are going to think ...

Patients with axSpA can wait 10 years after symptom onset to be diagnosed with the condition. There are currently no guidelines to advise clinicians on when to refer to a rheumatologist, and with the ...

Please provide your email address to receive an email when new articles are posted on . Spondyloarthritis in pregnancy is associated with an increased risk for several adverse outcomes, including ...

If you’re like most people who have axial spondyloarthritis (axSpA), you’ve waited years, perhaps even more than a decade, before getting a diagnosis. But now that you have one, the next step is to ...

NEW BEDFORD — When Jonathan Kastin was 21 years old and a student at Smith College in Northampton, he started having pains in his hands and wrists. The pain became increasingly worse as it traveled to ...

Remote monitoring and patient-initiated care matched usual care in maintaining low disease activity in patients with axial spondyloarthritis (axSpA) on stable TNF inhibitor therapy. Researchers ...

Adding methotrexate to adalimumab (Humira) in axial spondyloarthritis was associated with reduced immunogenicity, as shown by a lower rate of developing antidrug antibodies, French researchers ...

The Dutch CaFaSpA study (van Hoeven et al. 2014, 2015) should be repeated in a UK population. This would involve examining GP databases to identify a cohort of people who have a diagnosis of ...